Proteasome Inhibition: A Promising Strategy for Treating Cancer, but What About Neurotoxicity?

E-ISSN： 1875-533x|15|29|3025-3035

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.29, 2008-12, pp. : 3025-3035

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

mTOR Inhibition in Lymphoma: A Rational and Promising Strategy

Letters in Drug Design & Discovery, Vol. 4, Iss. 3, 2007-04 ,pp. : 224-231

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting syndecans: a promising strategy for the treatment of cancer

By Choi Sojoong

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 6, 2013-09 ,pp. : 695-705

Informa Healthcare

Access to resources Recommend Favorite

Bortezomib: Proteasome Inhibition as a Novel Mechanism of Cancer Therapy-Implications for Hematological Malignancies

Letters in Drug Design & Discovery, Vol. 4, Iss. 2, 2007-03 ,pp. : 82-86

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Vascular Endothelial Growth Factor: A Promising Strategy for Treating Age-Related Macular Degeneration

By Waisbourd Michael Loewenstein Anat Goldstein Michaella Leibovitch Igal

Drugs & Aging, Vol. 24, Iss. 8, 2007-01 ,pp. : 643-662

Adis International

Access to resources Recommend Favorite

LSD1 inhibition: a therapeutic strategy in cancer?

By Lynch James T Harris William J Somervaille Tim C P

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1239-1249

Informa Healthcare

Access to resources Recommend Favorite